These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3609243)

  • 1. Morphological and histochemical changes in intestinal mucosa in the reserpine-treated rat model of cystic fibrosis.
    Park CM; Reid PE; Owen DA; Sanker JM; Applegarth DA
    Exp Mol Pathol; 1987 Aug; 47(1):1-12. PubMed ID: 3609243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of reserpine on the histochemical and biochemical properties of rat intestinal mucin.
    Forstner J; Roomi N; Khorasani R; Kuhns W; Forstner G
    Exp Mol Pathol; 1991 Apr; 54(2):129-43. PubMed ID: 2029934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal secretion of mucin in chronically reserpine-treated rats.
    Forstner J; Maxwell B; Roomi N
    Am J Physiol; 1981 Nov; 241(5):G443-50. PubMed ID: 6795937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histochemical characteristics of mucins in the small intestine. A comparative study of normal mucosa, benign epithelial tumours and carcinoma.
    Filipe MI; Fenger C
    Histochem J; 1979 May; 11(3):277-87. PubMed ID: 457439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute and chronic models for hypersecretion of intestinal mucin.
    Forstner J; Roomi N; Fahim R; Gall G; Perdue M; Forstner G
    Ciba Found Symp; 1984; 109():61-71. PubMed ID: 6569839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The chronically reserpinized rat as a possible animal model for cystic fibrosis. IV. The protein composition of pulmonary lavage fluid.
    Thompson FE; Quissell DO; Williams CH; Martinez JR
    Pediatr Res; 1976 Jun; 10(6):632-5. PubMed ID: 946902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histochemical changes in the composition of mucins in goblet cells during methotrexate-induced mucosal atrophy in rats.
    Koninkx JF; Stemerdink AF; Mirck MH; Egberts HJ; van Dijk JE; Mouwen JM
    Exp Pathol; 1988; 34(3):125-32. PubMed ID: 3197798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of malnutrition and chronic reserpine treatment on pancreatic exocrine function.
    Hazlett D; Korc M; Brannon PM
    Pediatr Res; 1986 Dec; 20(12):1236-9. PubMed ID: 2432455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional and morphological changes of the gut barrier during the restitution process after hemorrhagic shock.
    Chang JX; Chen S; Ma LP; Jiang LY; Chen JW; Chang RM; Wen LQ; Wu W; Jiang ZP; Huang ZT
    World J Gastroenterol; 2005 Sep; 11(35):5485-91. PubMed ID: 16222741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosubstance histochemistry of the normal mucosa and carcinoma of the large intestine. Galactose oxidase-Schiff reaction and lectin stainings.
    Katsuyama T; Ono K; Nakayama J; Akamatsu T; Honda T
    Acta Pathol Jpn; 1985 Nov; 35(6):1409-25. PubMed ID: 2418624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tracheal potential difference in the reserpine and isoproterenol rat models of cystic fibrosis.
    Rogers DF; Alton EW; Dewar A; Geddes DM; Barnes PJ
    Exp Lung Res; 1990; 16(6):661-70. PubMed ID: 2081507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The chronically reserpinized rat as a possible model for cystic fibrosis. I. Submaxillary gland morphology and ultrastructure.
    Martinez JR; Adelstein E; Quissel D; Barbero GJ
    Pediatr Res; 1975 May; 9(5):463-9. PubMed ID: 166347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The chronically isoproterenol-treated rat in the study of cystic fibrosis: X-ray microanalysis of the submandibular gland.
    Müller RM; Roomans GM
    Exp Mol Pathol; 1984 Jun; 40(3):391-400. PubMed ID: 6723939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma immunoreactive cationic trypsin(ogen) pattern in reserpinized rat model of cystic fibrosis. Resemblance to humans.
    Weizman Z
    Dig Dis Sci; 1996 May; 41(5):853-8. PubMed ID: 8625754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The chronically reserpinized rat as a model for cystic fibrosis: alterations in the mucus-secreting sublingual gland.
    Martinez JR; Bylund DB; Mawhinney T; Camden J; Ray G
    Pediatr Res; 1983 Jul; 17(7):523-8. PubMed ID: 6622094
    [No Abstract]   [Full Text] [Related]  

  • 16. Goblet cell hyperplasia is a feature of the adaptive response to jejunoileal bypass in rats.
    Olubuyide IO; Williamson RC; Bristol JB; Read AE
    Gut; 1984 Jan; 25(1):62-8. PubMed ID: 6690374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eradication of small intestinal bacterial overgrowth in the cystic fibrosis mouse reduces mucus accumulation.
    De Lisle RC; Roach EA; Norkina O
    J Pediatr Gastroenterol Nutr; 2006 Jan; 42(1):46-52. PubMed ID: 16385253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The chronically reserpinized rat as a possible model for cystic fibrosis. II. Comparison and cilioinhibitory effects of submaxillary saliva.
    Martinez JR; Adshead PC; Quissell DO; Barbero GJ
    Pediatr Res; 1975 May; 9(5):470-5. PubMed ID: 1134845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical characterization of the component parts of intestinal mucin from patients with cystic fibrosis.
    Mantle M; Forstner GG; Forstner JF
    Biochem J; 1984 Dec; 224(2):345-54. PubMed ID: 6517857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective goblet cell exocytosis contributes to murine cystic fibrosis-associated intestinal disease.
    Liu J; Walker NM; Ootani A; Strubberg AM; Clarke LL
    J Clin Invest; 2015 Mar; 125(3):1056-68. PubMed ID: 25642775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.